[Federal Register Volume 70, Number 227 (Monday, November 28, 2005)]
[Notices]
[Pages 71321-71322]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-23338]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which could 
constitute a clearly unwarranted invasion of personal privacy.


[[Page 71322]]


    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel, Insulin Resistance in PCOS--
Sequelae and Treatment.
    Date: November 30, 2005.
    Time: 2 p.m to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6100 Executive Boulevard, 
Room 5B01, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Gopal M. Bhatnagar, PhD, Scientific Review 
Administrator, National Institute of Child Health and Human 
Development, National Institutes of Health, 6100 Bldg. Rm. 5B01, 
Rockville, MD 20852, (301) 435-6889, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: November 18, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-23338 Filed 11-25-05; 8:45 am]
BILLING CODE 4140-01-M